Robert Waltermire

Corporate Officer/Principal at MADRIGAL PHARMACEUTICALS, INC.

Net worth: 1 M $ as of 2024-04-29

61 year

99 connections

Consumer Services

Health Technology

Commercial Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Paul Friedman	M	81	MADRIGAL PHARMACEUTICALS, INC.	8 years
Fred Craves	M	78	MADRIGAL PHARMACEUTICALS, INC.	13 years
Rebecca Taub	M	71	MADRIGAL PHARMACEUTICALS, INC.	8 years
William Sibold	M	57	MADRIGAL PHARMACEUTICALS, INC.	1 years
Edward Chiang	M	-	MADRIGAL PHARMACEUTICALS, INC.	13 years
Luigi Xerri	M	-	Venatorx Pharmaceuticals, Inc. Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA.	14 years
Richard Levy	M	66	MADRIGAL PHARMACEUTICALS, INC.	8 years
Ken Bate	M	73	MADRIGAL PHARMACEUTICALS, INC.	8 years
James Daly	M	62	MADRIGAL PHARMACEUTICALS, INC.	5 years
Julian Baker	M	57	MADRIGAL PHARMACEUTICALS, INC.	1 years
Daniel Pevear	M	-	Venatorx Pharmaceuticals, Inc. Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA.	14 years
Charles K. Nicholas	M	-	University of Maryland	36 years
Christopher Frates	M	-	MADRIGAL PHARMACEUTICALS, INC.	3 years
Tina Ventura	F	-	MADRIGAL PHARMACEUTICALS, INC.	-
Mark Barrett	M	-	MADRIGAL PHARMACEUTICALS, INC.	-
Raymond Cheong	M	42	MADRIGAL PHARMACEUTICALS, INC.	1 years
Dominic F. Labriola	M	-	MADRIGAL PHARMACEUTICALS, INC.	2 years
Stephen Dodge	M	-	MADRIGAL PHARMACEUTICALS, INC.	-
Carole Huntsman	F	59	MADRIGAL PHARMACEUTICALS, INC.	-
Ronald Filippo	M	-	MADRIGAL PHARMACEUTICALS, INC.	1 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Christopher Burns	M	-	Venatorx Pharmaceuticals, Inc. Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA.	14 years
Qiang Yang	M	62	University of Maryland	5 years
Timothy Johnson	M	-	University of Maryland	6 years
Irwin Chen	M	-	University of Maryland	3 years
Rajiv Laroia	M	61	University of Maryland	4 years
Alex Howarth	M	55	MADRIGAL PHARMACEUTICALS, INC.	3 years
Keith Gollust	M	78	MADRIGAL PHARMACEUTICALS, INC.	7 years
Kamil Yilmaz	M	-	University of Maryland	5 years
David Milligan	M	83	MADRIGAL PHARMACEUTICALS, INC.	7 years
Jin Kang	M	59	University of Maryland	5 years
Yagyensh Pati	M	60	University of Maryland	6 years
David Price	M	59	University of Maryland	4 years
Frank Ruffo	M	58	Venatorx Pharmaceuticals, Inc. Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA.	3 years
Dale Fuller	M	-	University of Maryland	4 years
Bret Minark	M	-	University of Maryland	4 years
Cynthia L. Spell	F	-	University of Maryland	3 years
Matt Theurer	M	-	University of Maryland	4 years
Gary E. Fitch	M	-	University of Maryland	2 years
Craig A. Anderson	M	-	University of Maryland	2 years
David Steinberg	M	-	University of Maryland	4 years
Steven D. List	M	-	University of Maryland	4 years
Lin Lin Zhou	M	63	University of Maryland	3 years
Paul C. Boudrye	M	60	University of Maryland	4 years
Jerry Wollman	M	-	University of Maryland	4 years
David H. Jung	M	-	University of Maryland	4 years
Greg A. Carter	M	-	University of Maryland	4 years
John Andrew McCarthy	M	60	University of Maryland	3 years
Peter Burton	M	-	University of Maryland	4 years
Mario Arace	M	-	University of Maryland	3 years
Jeffrey Gillis	M	-	University of Maryland	4 years
Minh N. Le	M	58	University of Maryland	4 years
Curtis Ervin	M	-	University of Maryland	4 years
Tony V. Steelman	M	-	University of Maryland	4 years
Eugene Bredow	M	54	University of Maryland	4 years
Steve Sarnecki	M	-	University of Maryland	4 years
Sang Na	M	-	University of Maryland	5 years
Russell L. Lamb	M	-	University of Maryland	1 years
Song K. Jung	M	-	University of Maryland	4 years
Paul Jamess Carroll	M	-	University of Maryland	2 years
Edward Albrigo	M	-	University of Maryland	2 years
Scott C	M	-	University of Maryland	5 years
Ted Patch	M	-	University of Maryland	4 years
Steven H. Krein	M	-	University of Maryland	4 years
Kamlesh Miller	F	-	University of Maryland	4 years
Thomas David Teles	M	-	University of Maryland	4 years
Laura A. Evans	F	-	University of Maryland	4 years
Robert W. Henley	M	57	University of Maryland	4 years
Kevin Smith	M	-	University of Maryland	4 years
Greg Myers	M	-	University of Maryland	4 years
Anne Nisenson Mathias	F	-	University of Maryland	3 years
Farukh Z. Farooqi	M	-	University of Maryland	4 years
Mike Dellapa	M	-	University of Maryland	4 years
Corey Silverman	M	-	University of Maryland	4 years
Martin Friedman	M	73	University of Maryland	3 years
Eugene I. Maddred	M	-	University of Maryland	4 years
Vivien Liu	F	-	University of Maryland	4 years
Jill Taymans	F	55	University of Maryland	4 years
Norman Cohen	M	97	University of Maryland	4 years
Mark P. Huston	M	-	University of Maryland	4 years
Keith Washington	M	-	University of Maryland	4 years
Marc Blazer	M	-	University of Maryland	4 years
Allan Michael Budelman	M	-	University of Maryland	4 years
Andrew Gerber	M	56	University of Maryland	4 years
Michael W. Jarmolowich	M	-	University of Maryland	4 years
Jeffrey Greenberg	M	-	University of Maryland	4 years
Robert Kamfar	M	60	University of Maryland	4 years
Gregory Hearne	M	-	University of Maryland	4 years
Ajoy Mallik	M	-	University of Maryland	4 years
Jesús Pérez de Uriguen	M	53	University of Maryland	4 years
Italo D. Travez	M	-	University of Maryland	4 years
Bridget Rohde	F	-	University of Maryland	3 years
Eric Conn	M	-	University of Maryland	4 years
Keith Bachman	M	58	University of Maryland	4 years
Richard A. Borowski	M	-	University of Maryland	4 years
Dave A. Fike	M	56	University of Maryland	5 years
Pedro C. Herrera	M	-	University of Maryland	3 years
Cindy Rose Quackenbush	F	-	University of Maryland	4 years
David S. Evensky	M	-	University of Maryland	4 years
Greg Hanifee	M	-	University of Maryland	2 years

Statistics

Country	Connections	% of total
United States	99	100.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections